Orca Bio

orcabio.com

Orca Bio is a clinical-stage cell therapy company focused on redefining the transplant process through next-generation cell therapies. Their proprietary technologies aim to provide significantly better outcomes with fewer risks for patients suffering from hematological malignancies and autoimmune diseases. Founded in 2016, Orca Bio leverages advanced scientific insights and a unique cell-sorting platform to deliver high-precision investigational therapies. The company has administered its therapies to over 400 patients, positioning itself as a late-stage company with the agility of a startup, and is committed to expanding the life-changing benefits of cell therapies.